Li G H, Li J Q
J Surg Oncol. 1986 Aug;32(4):208-10. doi: 10.1002/jso.2930320405.
Clinical and experimental evidence shows that hepatic artery ligation (HAL) is an effective method for treatment of nonresectable primary liver carcinoma (PLC). Improvement of subjective symptoms in 50-70% patients has reported, although effective duration is short and 30-50% of the enlarged liver could be decreased. Usually, arterial collateral of the tumors after HAL may be evident again in 4-6 weeks. There is arteriographic evidence of the appearance of collateral flow as early as the fourth days after HAL. HAL combined with irradiation was carried out in 17 cases between October 1978 to October 1982 in order to improve the prognosis of nonresectable PLC.
临床和实验证据表明，肝动脉结扎术（HAL）是治疗不可切除原发性肝癌（PLC）的有效方法。据报道，50%至70%的患者主观症状有所改善，尽管有效持续时间较短，且肿大肝脏的30%至50%可缩小。通常，HAL术后肿瘤的动脉侧支在4至6周后可能再次显现。血管造影证据显示，HAL术后最早在第四天就会出现侧支血流。为改善不可切除PLC的预后，1978年10月至1982年10月期间对17例患者实施了HAL联合放疗。
